• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.25 Down 0.04(3.10%) May 29, 4:05PM EDT
    |After Hours : 1.25 0.00 (0.00%) May 29, 4:24PM EDT
    Add to Portfolio
    Prev Close:1.29
    Open:1.28
    Bid:1.28 x 7200
    Ask:1.29 x 3700
    1y Target Est:5.00
    Beta:1.04
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:1.25 - 1.31
    52wk Range:0.97 - 2.02
    Volume:598,186
    Avg Vol (3m):452,478
    Market Cap:187.42M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 3.10%187.42M
    LLYUp 3.26%83.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.16
    Quarterly EPS Est (Jun-15) :-0.04
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback